 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

---
- Obalon Therapeutics (NASDAQ:OBLN) and Aethlon Medical (NASDAQ:AEMD) are both small-cap
  medical companies, but which is the better business? We will contrast the two companies
  based on the strength of their profitability, institutional ownership, earnings,
  risk, analyst recommendations, dividends and...


Reviewing Obalon Therapeutics (NASDAQ:OBLN) and Aethlon Medical (NASDAQ:AEMD)

---
- Obalon Therapeutics, Inc. (NASDAQ:OBLN) major shareholder Armistice Capital, Llc
  sold 511,676 shares of the companys stock in a transaction dated Wednesday, June
  16th. The stock was sold at an average price of $6.92, for a total value of $3,540,797.92.
  The transaction was disclosed in a document ...


Armistice Capital, Llc Sells 511,676 Shares of Obalon Therapeutics, Inc. (NASDAQ:OBLN) Stock

---
- Obalon Therapeutics, Inc. (NASDAQ:OBLN) major shareholder Armistice Capital, Llc
  sold 685,583 shares of the businesss stock in a transaction on Friday, June 18th.
  The stock was sold at an average price of $5.48, for a total transaction of $3,756,994.84.
  The transaction was disclosed in a ...


Insider Selling: Obalon Therapeutics, Inc. (NASDAQ:OBLN) Major Shareholder Sells 685,583 Shares of Stock

---
- Obalon Therapeutics (NASDAQ:OBLN) and iCAD (NASDAQ:ICAD) are both small-cap medical
  companies, but which is the superior investment? We will contrast the two companies
  based on the strength of their dividends, institutional ownership, valuation, risk,
  earnings, analyst recommendations and ...


Financial Survey: Obalon Therapeutics (NASDAQ:OBLN) versus iCAD (NASDAQ:ICAD)

---
- Obalon Therapeutics (NASDAQ:OBLN) and Sintx Technologies (NASDAQ:SINT) are both
  small-cap medical companies, but which is the better stock? We will contrast the
  two companies based on the strength of their dividends, earnings, analyst recommendations,
  profitability, institutional ownership, ...


Sintx Technologies (NASDAQ:SINT) and Obalon Therapeutics (NASDAQ:OBLN) Financial Contrast

---
- SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 15, 2021 / ReShape Lifesciences
  Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today the
  anticipated closing of their previously announced merger to be effective after the
  close of the market today, June 15, 2021. The...


ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger

---
- A whopping number of 13F filings filed with U.S. Securities and Exchange Commission
  has been processed by Insider Monkey so that individual investors can look at the
  overall hedge fund sentiment towards the stocks included in their watchlists. These
  freshly-submitted public filings disclose money...


Hedge Funds Are Betting On Obalon Therapeutics, Inc. (OBLN)

---
- Although the masses and most of the financial media blame hedge funds for their
  exorbitant fee structure and disappointing performance, these investors have proved
  to have great stock picking abilities over the years (thats why their assets under
  management continue to swell). We believe...


Is Obalon Therapeutics, Inc. (OBLN) Going to Burn These Hedge Funds?

---
- Ra Medical Systems (NYSE:RMED) and Obalon Therapeutics (NASDAQ:OBLN) are both small-cap
  medical companies, but which is the better business? We will contrast the two companies
  based on the strength of their earnings, institutional ownership, risk, analyst
  recommendations, dividends, valuation and ...


Head-To-Head Analysis: Ra Medical Systems (NYSE:RMED) & Obalon Therapeutics (NASDAQ:OBLN)

---
- SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 8, 2021 / ReShape Lifesciences
  Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today that
  the parties anticipate the closing of their previously announced merger to occur
  promptly after approval of their pending Nasdaq...


ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger

ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates though the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in San Clemente, CA.

Watchers	12,811
52-Wk Low	$0.1856
52-Wk High	$22.40

Market Cap	$3.45M
Volume (M)	79,802.00
52-Wk High	$22.40
52-Wk Low	$0.1856

OBLN Obalon Therapeutics

About

Feed

News

Fundamentals